Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Imiołczyk, Apolonia
DOB: 10-JUN-1964 (Age: 61)
Gender: female
Address:
plac Plater 96
43-300 Bielsko-Biała (Poland)
ID: 9441-183492-5 (ECI)
Report
Date: 02-JUL-2019
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Diagmed
Komorowicka 23
43-300 Bielsko-Biała (Poland)
Specimen
Collected: 02-JUL-2019

Chemistry

Test 02-JUL-2019 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 132.3 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 116.0 0 - 149 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 64.6 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 44.5 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All lipid parameters are within normal limits. No evidence of dyslipidemia at this time. Continue routine monitoring and maintain a healthy lifestyle. No laboratory abnormalities detected.